Dissociation between IFN-α-induced anti-viral and growth signaling pathways

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3289-3297

  Arora, Taruna ^a   Floyd Smith, Georgia ^c   Espy, Mark J ^b   Jelinek, Diane F ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; HLA ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; WORTMANNIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVATION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; MYELOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS RESISTANCE;

2',5'-OLIGOADENYLATE SYNTHETASE; ANTIVIRAL AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL DIVISION; CYTOMEGALOVIRUS INFECTIONS; ENZYME ACTIVATION; FLAVONOIDS; GENE EXPRESSION REGULATION; GROWTH INHIBITORS; HUMANS; IMMUNITY, NATURAL; INTERFERON-ALPHA; MAP KINASE KINASE 1; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MULTIPLE MYELOMA; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0033559537     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brenning, G., A. Ahre, and K. Nilsson. 1985. Correlation between in vitro and in vivo sensitivity to human leukocyte interferon in patients with multiple myeloma. Scand. J. Haemotol. 35:543.
2. Oken, M. M. 1994. Standard treatment of multiple myeloma. Mayo Clin. Proc. 69:781.
3. Pestka, S., J. Langer, K. C. Zoon, and C. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727.
4. Domanski, P., and O. R. Colamonici. 1996. The type-1 interferon receptor: the long and short of it. Cytokine Growth Factor Rev. 7:143.
5. Ghislain, J., G. Sussman, S. Goelz, D. E. Ling, and E. N. Fish. 1995. Configuration of the interferon-α/β receptor complex determines the context of the biological response. J. Biol. Chem. 270:21785.
6. Colamonici, O. R., B. Porterfield, P. Domanski, S. Contastinescu, and L. M. Pfeffer. 1994. Complementation of the IFN-α response in resistant cells by expression of the cloned subunit of the interferon α receptor: a central role of this subunit in interferon α signaling. J. Biol. Chem. 269:9598.
7. 1yk2 tyrosine kinase. Mol. Cell. Biol. 14:8133.
8. Ihle, J. N. 1996. STATs: Signal transducers and activators of transcription. Cell 84:331.
9. David, M. 1995. Transcription factors in interferon signaling. Pharmacol. Ther. 65:149.
10. Friedman, R. L., S. P. Manly, M. McMahon, I. M. Kerr, and G. R. Stark. 1984. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38:745.
11. Levy, D. E., A. C. Larner, A. Chaudhury, L. E. Baiss, and J. E. Darnell. 1986. Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc. Natl. Acad. Sci. USA 83:8929.
12. Reich, N., B. Evans, D. E. Levy, D. Fahey, E. Knight, and J. E. Darnell. 1987. Interferon-induced transcription of a gene encoding a 15 kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA 84:6394.
13. Rice, A. P., R. Duncan, J. W. Hershey, and I. M. Kerr. 1985. Double-stranded RNA-dependent protein kinase and 2′-5′ A system are both activated in an interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54:894.
14. Williams, B. R. G., and I. M. Kerr. 1980. The 2-5A (pppA2′p5′A2′p5′A) system in interferon-treated and control cells. Trends Biochem. Sci. 5:138.
15. McMahon, M., G. R. Stark, and I. M. Kerr. 1986. Interferon-inducible gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells. J. Virol. 57:362.
16. Hwang, S. Y., P. J. Hertzog, K. A. Holland, S. H. Sumarsono, M. J. Tymms, J. A. Hamilton, G. Whitty, I. Bertoncello, and I. Kola. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferon α and β and alters macrophage responses. Proc. Natl. Acad. Sci. USA 92:11284.
17. Rodig, S. J., M. A. Meraz, J. M. White, P. A. Lampe, J. K. Riley, C. D. Arthur, K. L. King, K. C. F. Sheehan, L. Yin, D. Pennica, et al. 1998. Disruption of the JAK1 gene demonstrates obligatory and nonredundant roles of the JAKs in cytokine-induced biologic responses. Cell 93:373.
18. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the STAT1 gene reveals unexpected physiological specificity in the JAK-STAT signaling pathway. Cell 84:431.
19. Joneson, T., and Bar-Sagi D. 1997. Ras effectors and their roles in mitogenesis and oncogenesis. J. Mol. Med. 75:587.
20. Sakatsume, M., L. F. Stancato, M. David, O. Silvennoinen, P. Saharinen, J. Pierce, A. C. Lamer, and D. S. Finbloom. 1998. Interferon γ activation of Raf-1 is Jak1-dependent and p21ras-independent. J. Biol. Chem. 273:3021.
21. Stancato, L. F., M. Sakatsume, M. David, P. Dent, F. Dong, E. F. Petricoin, J. J. Krolewski, O. Silvennoinen, P. Saharinen, J. Pierce, et al. 1997. β Interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol. Cell. Biol. 17:3833.
22. David, M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAPK (ERK2) activity in interferon α- and interferon β-stimulated gene expression. Science 269:1721.
23. Uddin, S., E. N. Fish, D. A. Sher, C. Gardziola, M. F. White, and L. C. Platanias. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-α. J. Immunol. 158:2390.
24. Jelinek, D. F., K. M. Aagaard-Tillery, B. K. Arendt, T. Arora, R. C. Tschumper, and J. J. Westendorf. 1997. Differential human multiple myeloma cell line responsiveness to IFN-α: analysis of transcriptional factor activation and interleukin 6 receptor expression. J. Clin. Invest. 99:447.
25. Jelinek, D. F., G. J. Ahmann, P. R. Greipp, S. M. Jalal, J. J. Westendorf, J. A. Katzmann, R. A. Kyle, and J. A Lust. 1993. Coexistence of aneuploid clones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer Res. 53:5320.
26. Colamonici, O. R., and P. Domanski. 1993. Identification of a novel subunit of the type I Interferon receptor localized to human chromosome 21. J. Biol. Chem. 268:10895.
27. Jelinek, D. F., T. E. Witzig, and B. K. Arendt. 1997. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. J. Immunol. 159:487.
28. Floyd-Smith, G., and P. Lengyel. 1986. RNase L. a (2′-5′)-oligoadenylate dependent endoribonuclease: assays and purification of the enzyme. Methods Enzymol. 119:489.
29. Jenab, S., and P. L. Morris. 1997. Transcriptional regulation of Sertoli cell immediate early genes by interleukin-6 and interferon-γ is mediated through phospnorylation of stat-3 and stat-1 proteins. Endocrinology 138:2740.
30. Boulton, T. G., Z. Zhong, Z. Wen, and J. E. Darnell. 1995. Stat3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92:6915.
31. Raveh, T., A. G. Hovanessian, E. F. Meurs, N. Sonenberg, and A. Kimchi. 1996. Double stranded RNA dependent protein kinase mediates c-Myc suppression induced by type I interferons. J. Biol. Chem. 271:25479.
32. Jelinek, D. F., and T. Arora. 1997. Effects of interferon-α on myeloma cells: mechanisms of differential responsiveness. Curr. Top. Microbiol. Immunol. 224: 261.
33. Reich, N. C., and L. M. Pfeffer. 1990. Evidence for involvement of protein kinase C in the cellular response to Interferon α. Proc. Natl. Acad. Sci. USA 87:8761.
34. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by stat1 and stat3 requires both tyrosine and serine phosphorylation. Cell 82:241.
35. Muller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. E. Darnell, Jr., G. R. Stark, and I. M. Kerr. 1993. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221.
36. Bandyopadhyay, S. K., D. V. R. Kalvakolanu, and G. C. Sen. 1990. Gene induction by interferons: functional complementation between trans-acting factors induced by α Interferon and γ interferon. Mol. Cell. Biol. 10:5055.
37. Petricoin, E. F., III, S. Ito, B. L. Williams, S. Audet, L. F. Stancato, A. Gamero, K. Clouse, P. Grimley, A. Weiss, J. Beeler, et al. 1997. Antiproliferative action of interferon-α requires components of T cell receptor signaling. Nature 390:629.
38. INK4d and cyclin D2 expression. J. Biol. Chem. 273:11799.